Cervical cancer is the third most
common gynecologic cancer in the United States, and takes the life of one of every three women diagnosed with it.
Not exact matches
This study adds to the discussion about the role of this immunosurveillance in the risk of developing the
common cancers among those with compromised immune systems,» adds first author Paul Mayor, MD, Fellow in the Department of
Gynecologic Oncology at RPCI.
The researchers» next steps will involve expansion of the biomarkers identified in this study to other
cancer types, especially breast
cancer, due to the hormonal input that is a
common factor in
gynecologic tumors.
Endometrial
cancer is the most
common type of
gynecologic cancer in developed countries.